Calamos Select Fund I holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Calamos Select Fund Institutional Class CVAIX
- NAV / 1-Day Return 25.17 / −2.33 %
- Total Assets 64.1M
-
Adj. Expense Ratio
0.900%
- Expense Ratio 0.900%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.04%
- Turnover 46%
USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 1:05 AM GMT+0
Morningstar’s Analysis CVAIX
Will CVAIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the CVAIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of CVAIX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 46.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Alphabet Inc Class A | 7.58 | 4M | Communication Services |
NVIDIA Corp | 7.54 | 4M | Technology |
Apple Inc | 7.02 | 4M | Technology |
Amazon.com Inc | 5.71 | 3M | Consumer Cyclical |
Microsoft Corp | 5.12 | 3M | Technology |
Broadcom Inc | 3.65 | 2M | Technology |
Meta Platforms Inc Class A | 2.78 | 2M | Communication Services |
Chevron Corp | 2.55 | 1M | Energy |
Johnson & Johnson | 2.37 | 1M | Healthcare |
Eli Lilly and Co | 2.21 | 1M | Healthcare |
United States